Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Location: Basel Switzerland, 3 days/week in office About The Role The Global Head of Technology & Architecture in Biomedical Research (BR) will spearhead our information technology strategy in drug discovery and early clinical development, ensuring our technologies
Executive Director, IT Business Partner – Advanced Synthesis Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Industry: Marketing & Event Industry Number of employees: approx 1400 worldwide / 400 CH Reference number: 63X587WR Key Facts: SAP HR Ownership, SAP SuccessFactors, SAP Concur, SAP Cloud Platform integrations, project management, stakeholder management, in Basel/home
